Annotation Detail

Information
Associated Genes
KIT
Associated Variants
KIT EXON 11 MUTATION
KIT EXON 11 MUTATION
Associated Disease
melanoma
Source Database
CIViC Evidence
Description
10 melanoma patients were evaluated after sunitinib treatment, among which 3 out of the 4 patients with KIT exon 11 mutations showed either complete or partial response.
Variant Origin
somatic
Variant Origin
Somatic
Evidence URL
https://civic.genome.wustl.edu/links/evidence_items/1224
Gene URL
https://civic.genome.wustl.edu/links/genes/29
Variant URL
https://civic.genome.wustl.edu/links/variants/66
Rating
3
Evidence Type
Predictive
Disease
Melanoma
Evidence Direction
Supports
Drug
Sunitinib
Evidence Level
C
Clinical Significance
Sensitivity/Response
Pubmed
22261812
Drugs
Drug NameSensitivitySupported
SunitinibSensitivitytrue